Skip to main content

Advertisement

SpringerLink
Log in

Ranbaxy facility prohibited from producing/distributing APIs for US

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Food and Drug Administration. FDA prohibits Ranbaxy's Toansa, India facility from producing and distributing drugs for the U.S. market. Media Release : 23 Jan 2014. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ranbaxy facility prohibited from producing/distributing APIs for US. Reactions Weekly 1488, 3 (2014). https://doi.org/10.1007/s40278-014-8750-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-8750-2

Search

Navigation